Two more patients have died in Guinea's Ebola outbreak, pushing the number of fatal cases to 80.
Lab tests have confirmed Ebola in two patients from a district that borders Guinea.
Guinea's health officials, during a press briefing today on the country's Ebola outbreak, reported that the number of viral hemorrhagic fever cases has reached 112, 70 of them fatal, up from 88 cases and 66 deaths reported yesterday. An account of the press briefing appeared in a French-language report in the Guinea-based Le Jour newspaper, which was translated and posted by H5N1 Blog, an infectious disease news site.
The number of suspected and confirmed cases in the nation climbed from 86 to 103.
In an update today on the Ebola virus outbreak in Guinea, the World Health Organization (WHO) African Regional Office said in a statement that two more patients have died, pushing the number of fatalities to 62. The number of suspected cases remained at 86, for a case-fatality ratio of 72%.
Ill patients in Liberia and Sierra Leone cause concern in what WHO calls 'rapidly evolving' Ebola outbreak.
The WHO today said Guinea has 86 suspected Ebola cases—13 of them lab-confirmed—and 59 deaths.
A Saudi man who contracted Middle East respiratory syndrome coronavirus (MERS-CoV) in November after tending sick camels had a virus nearly identical to that found in one of his camels, suggesting he contracted the disease from them, according to a letter yesterday in Emerging Infectious Diseases.
New York City's health department said yesterday that a rare skin disease has been identified in 30 people who handled live or raw fish or seafood bought in Chinatown markets in Manhattan, Brooklyn, or Queens.
Diethycarbamazine (DEC) has become the first medication prequalified by the World Health Organization (WHO) for treatment of a neglected tropical disease (NTD), namely lymphatic filariasis, the WHO announced today. The drug's Japanese manufacturer, Eisai Co. Ltd., has committed to donating 2.2 billion tablets over a 6-year period.
